Patents by Inventor Ken Fallin

Ken Fallin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20240285527
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: January 3, 2024
    Publication date: August 29, 2024
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • Composition and method for proton pump inhibitor suspension
    Patent number: 11813253
    Abstract: Suspensions of pump inhibitors (PPIs) are disclosed. The suspension may include a PPI, a copolymer of ethylene oxide and propylene oxide; simethicone emulsion; Sodium Bicarbonate; and Sodium Citrate, USP (Dihydrate). The suspensions have desirable viscosities and enhanced stability.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: November 14, 2023
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Ken Fallin, Kaity Renaud, Peter Mione, Neal Muni, Anisa Gandhi
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220395479
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and /or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 15, 2022
    Inventors: Ken FALLIN, Zeus Pendon, Priya Capila, Neal Muni
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220395480
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 15, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220370414
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 5, 2022
    Publication date: November 24, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220370349
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 5, 2022
    Publication date: November 24, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • Suspensions and diluents for metronidazole and baclofen
    Patent number: 11446246
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Grant
    Filed: April 21, 2022
    Date of Patent: September 20, 2022
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Ken Fallin, Zeus Pendon, Priya Capila, Neal Muni
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220257508
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220241197
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: April 21, 2022
    Publication date: August 4, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • COMPOSITION AND METHOD FOR PROTON PUMP INHIBITOR SUSPENSION
    Publication number: 20220152007
    Abstract: Suspensions of pump inhibitors (PPIs) are disclosed. The suspension may include a PPI, a copolymer of ethylene oxide and propylene oxide; simethicone emulsion; Sodium Bicarbonate; and Sodium Citrate, USP (Dihydrate). The suspensions have desirable viscosities and enhanced stability.
    Type: Application
    Filed: December 17, 2021
    Publication date: May 19, 2022
    Inventors: Ken FALLIN, Kaity RENAUD, Peter MIONE, Neal MUNI, Anisa GANDHI
  • Suspensions and diluents for metronidazole and baclofen
    Patent number: 11324696
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 10, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Ken Fallin, Zeus Pendon, Priya Capila, Neal Muni
  • Composition and method for proton pump inhibitor suspension
    Patent number: 11207307
    Abstract: Suspensions of pump inhibitors (PPIs) are disclosed. The suspension may include a PPI, a copolymer of ethylene oxide and propylene oxide; simethicone emulsion; Sodium Bicarbonate; and Sodium Citrate, USP (Dihydrate). The suspensions have desirable viscosities and enhanced stability.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: December 28, 2021
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Ken Fallin, Kaity Renaud, Peter Mione, Neal Muni, Anisa Gandhi
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20210220267
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and /or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: December 23, 2020
    Publication date: July 22, 2021
    Inventors: Ken Fallin, Zeus Pendon, Priya Capila, Neal Muni
  • COMPOSITION AND METHOD FOR PROTON PUMP INHIBITOR SUSPENSION
    Publication number: 20190321348
    Abstract: Suspensions of pump inhibitors (PPIs) are disclosed. The suspension may include a PPI, a copolymer of ethylene oxide and propylene oxide; simethicone emulsion; Sodium Bicarbonate; and Sodium Citrate, USP (Dihydrate). The suspensions have desirable viscosities and enhanced stability.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 24, 2019
    Applicant: CutisPharma, Inc.
    Inventors: Ken Fallin, Kaity Renaud, Peter Mione, Neal Muni, Anisa Gandhi
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20190282500
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension may include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: September 8, 2017
    Publication date: September 19, 2019
    Applicant: CutisPharma, Inc.
    Inventors: Ken Fallin, Zeus Pendon, Priya Capila, Neal Muni